(Q37237357)

19 August 2017

Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis (English)

1 reference

19 August 2017

F M Giardiello

1

1 reference

19 August 2017

E W Spannhake

2

1 reference

19 August 2017

R N DuBois

3

1 reference

19 August 2017

L M Hylind

4

1 reference

19 August 2017

C R Robinson

5

1 reference

19 August 2017

W C Hubbard

6

1 reference

19 August 2017

S R Hamilton

7

1 reference

19 August 2017

V W Yang

8

1 reference

19 August 2017

1 February 1998

1 reference

Digestive Diseases and Sciences

19 August 2017

1 reference

19 August 2017

43

1 reference

19 August 2017

2

1 reference

19 August 2017

311-316

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1018898120673

19 August 2017

0 references

cites work

Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Aspirin use and reduced risk of fatal colon cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Sulindac causes regression of rectal polyps in familial adenomatous polyposis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Prostaglandins from tumours of human large bowel

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Prostaglandins and cancer: A review of tumor initiation through tumor metastasis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Prostaglandins and cancer: an update

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Antiproliferative activity of anti-inflammatory drugs in two mammalian cell culture lines

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing ad

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Rectal cancer in FAP patient after sulindac.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

[Investigation of endogenous prostaglandins in DMH induced colonic cancer in rats].

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

A protective effect of sulindac against chemically-induced primary colonic tumours in mice.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancer

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Investigation of colonic prostaglandins in carcinogenesis in the rat colon.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Arrest of cultured cells in the G1 phase of the cell cycle by indomethacin

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Sulfone metabolite of sulindac inhibits mammary carcinogenesis.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700288

Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors

3 September 2018

1 reference

12 December 2020

Sulindac for polyposis of the colon

1 reference

12 December 2020

Profiling of prostaglandin biosynthesis in biopsy fragments of human lung carcinomas and normal human lung by capillary gas chromatography-negative ion chemical ionization mass spectrometry

1 reference

12 December 2020

Profiling of bisenoic prostaglandins and thromboxane B2 in bronchoalveolar fluid from the lower respiratory tract of human subjects by combined capillary gas chromatography-mass spectrometry

1 reference

12 December 2020

Effects of Long-term Sulindac Therapy on Colonic Polyposis

1 reference

12 December 2020

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals

1 reference

12 December 2020

Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy

1 reference

12 December 2020

Measurement of prostaglandin E2 in rectal mucosa in human subjects: a method study

1 reference

12 December 2020

Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam

1 reference

12 December 2020

Immunochemical measurement of prostaglandin or prostaglandin-like activity from normal and neoplastic cultured tissue

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1018898120673

1 reference

Dimensions Publication ID

19 August 2017

0 references

1 reference

19 August 2017

PubMed publication ID

9512123

1 reference